Ranexa (ranolozaine)
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 71 (Table of Contents)
Published: 6 May-2006
DOI: 10.3833/pdr.v2006.i71.513 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Ranolazine (piperazine acetamide) is a partial fatty acid oxidation (pFOX) inhibitor and represents a new class of metabolic inhibitors for the treatment of chronic stable angina (CSA)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS